Skip to main content
. 2023 Jul 21;13:1222716. doi: 10.3389/fonc.2023.1222716

Figure 4.

Figure 4

(A) Changes in ctDNA abundance after EGFR-TKI treatment (dotted line) and chemotherapy (solid line) in 11 postoperative MRD-positive adenocarcinoma patients; X-axis represents follow-up time, Y-axis represents ctDNA abundance; (B) in vivo tumour ctDNA abundance in 4 patients with MRD-positive squamous cell carcinoma treated with chemotherapy + ICIs; X-axis represents follow-up time, Y-axis represents ctDNA abundance.